Cargando…
Identification of Three Antiviral Inhibitors against Japanese Encephalitis Virus from Library of Pharmacologically Active Compounds 1280
Japanese encephalitis virus (JEV) can cause severe central nervous disease with a high mortality rate. There is no antiviral drug available for JEV-specific treatment. In this study, a cytopathic-effect-based, high-throughput screening assay was developed and applied to screen JEV inhibitors from Li...
Autores principales: | Fang, Jin'e, Sun, Leqiang, Peng, Guiqing, Xu, Jia, Zhou, Rui, Cao, Shengbo, Chen, Huanchun, Song, Yunfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857149/ https://www.ncbi.nlm.nih.gov/pubmed/24348901 http://dx.doi.org/10.1371/journal.pone.0078425 |
Ejemplares similares
-
Structure-based discovery of two antiviral inhibitors targeting the NS3 helicase of Japanese encephalitis virus
por: Fang, Jin’e, et al.
Publicado: (2016) -
Japanese Encephalitis Virus NS1′ Protein Interacts with Host CDK1 Protein to Regulate Antiviral Response
por: Li, Qiuyan, et al.
Publicado: (2021) -
Roles of TLR3 and RIG-I in Mediating the Inflammatory Response in Mouse Microglia following Japanese Encephalitis Virus Infection
por: Jiang, Rong, et al.
Publicado: (2014) -
Transcriptional regulation of miR-15b by c-Rel and CREB in Japanese encephalitis virus infection
por: Zhu, Bibo, et al.
Publicado: (2016) -
p21-Activated Kinase 4 Signaling Promotes Japanese Encephalitis Virus-Mediated Inflammation in Astrocytes
por: He, Wen, et al.
Publicado: (2017)